Furthermore, a recent extensive cohort study involving over 33,000 GLP-1 RA users diagnosed with diabetes over a 9-year period indicated no significant increase in pancreatic cancer risk associated with GLP-1 RA use, as evidenced by an HR of 0.50 compared to basal insulin [60]
For Marcus, this program meant a real shiftnot just a number on the scale, but more energy and hope
Palm Coast residents can consult with a licensed Florida weight loss doctor through secure telehealth
While GLP-1 RA drugs are effective, their high cost ( US$1,350/month) and side effects (nausea, stomach pain, heartburn) raise concerns, especially about what happens after stopping treatment
B6 plays a larger role in neurotransmitters, hormone balance, and recovery
The weight loss version of semaglutide (Wegovy) is not available in the UK yet, but it's coming